MX2008013777A - Usos medicos adicionales de la proteina antisecretora. - Google Patents

Usos medicos adicionales de la proteina antisecretora.

Info

Publication number
MX2008013777A
MX2008013777A MX2008013777A MX2008013777A MX2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A
Authority
MX
Mexico
Prior art keywords
caveolae
dysfunction
lipid rafts
antisecretory protein
receptors
Prior art date
Application number
MX2008013777A
Other languages
English (en)
Inventor
Hans-Arne Hansson
Original Assignee
Lantmaennen As Faktor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen As Faktor Ab filed Critical Lantmaennen As Faktor Ab
Publication of MX2008013777A publication Critical patent/MX2008013777A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con el uso de una proteína antisecretora, un derivado, homólogo, y/o fragmento, de la misma que tenga actividad equivalente, y/o un sal farmacéuticamente activa de la misma, para la elaboración de una composición farmacéutica y/o un alimento médico para el tratamiento y/o prevención de una disfunción, por ejemplo función anormal, hipo- o hiperfunción de balsas lipídicas, receptores y/o caveolass. Una disfunción de balsas lipídicas, receptores y/o caveolass, se puede provocar o ser la causa de una variedad de otras condiciones que se abarcan por la presente invención tales como, disfunciones vasculares, y pulmonares, y/o trastornos endocrinos, por ejemplo, diabetes y trastornos relacionados. Además, la invención se relaciona con un método para el tratamiento y/o prevención de la disfunción de balsas lipídicas y/o caveolas en un mamífero que necesita del mismo.
MX2008013777A 2006-04-27 2007-04-27 Usos medicos adicionales de la proteina antisecretora. MX2008013777A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600933 2006-04-27
US92082607P 2007-03-30 2007-03-30
PCT/SE2007/000415 WO2007126365A2 (en) 2006-04-27 2007-04-27 Further medical uses of antisecretory protein

Publications (1)

Publication Number Publication Date
MX2008013777A true MX2008013777A (es) 2009-02-03

Family

ID=38655930

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008013777A MX2008013777A (es) 2006-04-27 2007-04-27 Usos medicos adicionales de la proteina antisecretora.

Country Status (11)

Country Link
US (1) US8487074B2 (es)
EP (1) EP2037950B1 (es)
JP (2) JP5508846B2 (es)
KR (1) KR20090037992A (es)
AU (1) AU2007244005B2 (es)
CA (1) CA2650132C (es)
HK (1) HK1128237A1 (es)
IL (1) IL194775A (es)
MX (1) MX2008013777A (es)
PL (1) PL2037950T3 (es)
WO (1) WO2007126365A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5508846B2 (ja) 2006-04-27 2014-06-04 ラントメネン・アーエス−ファクトール・アーベー 脂質ラフトの調節
CN104689299B (zh) 2006-04-27 2020-02-21 兰特门内阿斯-法克托尔公司 抗分泌蛋白对于治疗间室综合症的应用
CN101432013B (zh) * 2006-04-27 2015-01-07 兰特门内阿斯-法克托尔公司 抗分泌因子对于治疗高眼压的应用
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
US8901083B2 (en) 2008-11-25 2014-12-02 Temple University Administration of angiocidin for the treatment of leukemia
JP5820277B2 (ja) * 2009-02-11 2015-11-24 ラントメネン・アーエス−ファクトール・アーベー 細胞取込を最適化するための抗分泌性因子（ａｆ）の使用
CN107949392B (zh) 2015-07-10 2022-10-11 兰特门内阿斯-法克托尔公司 用于生产含高含量af-16的蛋黄的方法
US11407796B2 (en) 2016-07-18 2022-08-09 Lantmännen As-Faktor Ab Antisecretory factor 17
CN112368014A (zh) * 2018-06-28 2021-02-12 兰特门内医疗公司 抗分泌因子在治疗和/或预防急性呼吸衰竭中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585401A (en) 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
EP0876483A1 (en) * 1996-01-26 1998-11-11 HSC Research and Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
SE506486C2 (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
JP5508846B2 (ja) 2006-04-27 2014-06-04 ラントメネン・アーエス−ファクトール・アーベー 脂質ラフトの調節
CN104689299B (zh) * 2006-04-27 2020-02-21 兰特门内阿斯-法克托尔公司 抗分泌蛋白对于治疗间室综合症的应用
EP2682819A2 (en) * 2012-07-04 2014-01-08 Xeikon IP B.V. A method for forming a multi-colour image

Also Published As

Publication number Publication date
WO2007126365A2 (en) 2007-11-08
WO2007126365A8 (en) 2009-03-05
US20090149382A1 (en) 2009-06-11
HK1128237A1 (en) 2009-10-23
CA2650132A1 (en) 2007-11-08
AU2007244005A1 (en) 2007-11-08
US8487074B2 (en) 2013-07-16
EP2037950A2 (en) 2009-03-25
JP2009535330A (ja) 2009-10-01
WO2007126365A3 (en) 2008-03-13
IL194775A (en) 2015-09-24
JP5508846B2 (ja) 2014-06-04
JP6063401B2 (ja) 2017-01-18
JP2014111623A (ja) 2014-06-19
EP2037950B1 (en) 2014-04-23
KR20090037992A (ko) 2009-04-17
IL194775A0 (en) 2011-08-01
PL2037950T3 (pl) 2014-09-30
AU2007244005B2 (en) 2012-08-02
CA2650132C (en) 2017-10-24

Similar Documents

Publication Publication Date Title
SG171601A1 (en) Further medical uses of antisecretory protein
MX2008013777A (es) Usos medicos adicionales de la proteina antisecretora.
WO2010126626A3 (en) Dual mechanism inhibitors for the treatment of disease
WO2008042688A3 (en) Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
WO2008076754A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2010123930A3 (en) Chemosensory receptor ligand-based therapies
WO2008050329A3 (en) Novel sirnas and methods of use thereof
WO2011041462A3 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
WO2011041729A3 (en) Compounds as lysophosphatidic acid receptor antagonists
WO2008080082A3 (en) Methods for modulating set and uses thereof
WO2010141768A3 (en) Polycyclic antagonists of lysophosphatidic acid receptors
WO2010077883A3 (en) Antagonists of lysophosphatidic acid receptors
WO2006047516A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2008076392A3 (en) Compounds useful as protein kinase inhibitors
WO2007120270A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
WO2008054208A3 (en) Use of nutritional compositions for preventing disorders
WO2007120284A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
WO2012021629A3 (en) Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
WO2009050136A3 (en) Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome
WO2007114855A3 (en) Glucagon receptor antagonists, preparation and therapeutic uses
ZA200810124B (en) Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol
WO2009038385A3 (en) Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
WO2010085820A3 (en) Tricyclic compounds as antagonists of prostaglandin d2 receptors
HK1124863A1 (en) Inhibitors of sodium glucose co-transporter 2 and methods of their use
WO2006133374A3 (en) Methods for treating shock

Legal Events

Date Code Title Description
FG Grant or registration